Kips Bay Medical, Inc.  

(Public, OTCMKTS:KIPS)   Watch this stock  
Find more results for kips
-0.010 (-5.26%)
Nov 25 - Close
OTCMKTS data delayed by 15 mins - Disclaimer
Currency in USD
Range 0.18 - 0.19
52 week 0.14 - 0.99
Open 0.19
Vol / Avg. 38,800.00/43,988.00
Mkt cap 6.27M
P/E     -
Div/yield     -
EPS -0.19
Shares 33.01M
Beta 2.94
Inst. own 2%
Nov 6, 2014
Q3 2014 Kips Bay Medical Inc Earnings Release

Key stats and ratios

Q3 (Sep '14) 2013
Net profit margin -10953.85% -4661.54%
Operating margin -10961.54% -4673.85%
EBITD margin - -4631.54%
Return on average assets -85.59% -66.72%
Return on average equity -92.34% -71.62%
Employees 14 -
CDP Score - -


United States - Map
+1-763-2353540 (Phone)
+1-763-2353545 (Fax)

Website links


Kips Bay Medical, Inc. is a medical device company focused on developing, manufacturing and commercializing its external saphenous vein support technology (eSVS MESH) for use in coronary artery bypass grafting (CABG) surgery. The Company�s eSVS MESH is a nitinol mesh sleeve that, when placed over a saphenous vein graft during CABG surgery, is designed to improve the structural characteristics and performance of the vein graft. The eSVS MESH is a kink-resistant extravascular tubular prosthesis made of knitted nickel/titanium, or nitinol, wire mesh.

Officers and directors

Manuel A. Villafana Chairman of the Board, Chief Executive Officer
Age: 74
Scott Kellen Chief Financial Officer, Chief Operating Officer, Vice President - Finance, Secretary
Age: 48
Randall Keith LaBounty Vice President - Regulatory and Clinical Affairs
Age: 51
Robert E. Munzenrider CPA Lead Independent Director
Age: 69
Robert J. Sheehy Independent Director
Age: 56
Arch C. Smith Independent Director